Medtronic To Pay Abbott $400M To Quell Stent Suits
Medtronic Inc. has agreed to pay Abbott Laboratories $400 million to settle all pending intellectual property litigation between the two companies worldwide over four patent families related to stents and rapid-exchange...To view the full article, register now.
Already a subscriber? Click here to view full article